Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02236364 · ClinicalTrials.gov registry record

Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye

A clinical trial, sponsored by University of Toledo Health Science Campus.

Terminated
Registry status
25
Enrollment target

NCT02236364: Clinical Trial study, sponsored by University of Toledo Health Science Campus.

NCT02236364 is a clinical trial that was terminated before completion, run by University of Toledo Health Science Campus. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02236364 was terminated before completion, sponsored by University of Toledo Health Science Campus.

TERMINATED
Registry status
25 participants
Enrollment target

Study Summary

Previous animal studies done by Dr. Brent Cameron in 2013 at the Univ. of Toledo have shown that glucose present in the fluid in the front of the eye, called the aqueous humor, correlates well with blood glucose. As blood glucose changes, the optical properties of the aqueous humor change, causing a change in the appearance of the iris of the eye.. The data collected in this study will be shared with IRISense to assist in validating the algorithm being used to develop the database needed. The data collected so far is in a narrow band of the normal glycemic range (healthy volunteers). We will collect standard digital photographic images of the eyes of subjects with diabetes along with corresponding blood glucose concentrations using the finger stick glucose monitoring method. In order to do this we will use standard digital photography techniques that is embedded in our benchtop prototype device

Primary Outcome

Eight digital photographic image of the subject's iris will be obtained at various times during each visit under standard illumination using the developed instrumentation. A point-of-care fingerstick blood glucose reading will be taken with an FDA approved blood glucose measurement device (i.e., Contour, Bayer Healthcare, LLC) as close to simultaneously as possible with the photograph.

Interventions

  • DEVICE Photographic Image Capture System

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2014-08
Est. Completion 2015-05

Why NCT02236364 stopped before completion

NCT02236364 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Photographic Image Capture System is the first listed.

NCT02236364 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02236364 about?

NCT02236364 is a clinical study titled "Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye". Previous animal studies done by Dr. Brent Cameron in 2013 at the Univ. of Toledo have shown that glucose present in the fluid in the front of the eye, called the aqueous humor, correlates well with blood glucose. As blood glucose changes, the optical properties of the aqueous humor change, causing a...

What is the current status of trial NCT02236364?

This trial is currently terminated. The enrollment target is 25 participants. The study started on 2014-08. Estimated completion is 2015-05.

What interventions are being tested in trial NCT02236364?

The interventions under investigation include: Photographic Image Capture System (DEVICE).

Who is sponsoring clinical trial NCT02236364?

This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02236364, the US trial registry maintained by the National Library of Medicine. NCT02236364 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.